Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis

被引:16
作者
Cheung, Alvin Ho-Kwan [1 ,2 ,3 ]
Hui, Chris Ho-Lam [1 ,2 ,3 ]
Wong, Kit Yee [1 ,2 ,3 ]
Liu, Xiaoli [1 ,2 ,3 ]
Chen, Bonan [1 ,2 ,3 ]
Kang, Wei [1 ,2 ,3 ]
To, Ka Fai [1 ,2 ,3 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, State Key Lab Digest Dis, Inst Digest Dis, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, State Key Lab Translat Oncol, Hong Kong, Peoples R China
关键词
cancer metabolism; CDK4; 6; cell cycle; metastasis; FOCAL ADHESION KINASE; CDK4/6; INHIBITION; BREAST-CANCER; ARGININOSUCCINATE SYNTHETASE; HEPATIC GLUCONEOGENESIS; GLUCOSE-TRANSPORTER; AMINO-ACID; IN-VITRO; REPLICATION STRESS; CARCINOMA CELLS;
D O I
10.1002/ijc.34288
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The use of cell cycle inhibitors has necessitated a better understanding of the cell cycle in tumor biology to optimize the therapeutic approach. Cell cycle aberrations are common in cancers, and it is increasingly acknowledged that these aberrations exert oncogenic effects beyond the cell cycle. Multiple facets such as cancer metabolism, immunity and metastasis are also affected, all of which are beyond the effect of cell proliferation alone. This review comprehensively summarized the important recent findings and advances in these interrelated processes. In cancer metabolism, cell cycle regulators can modulate various pathways in aerobic glycolysis, glucose uptake and gluconeogenesis, mainly through transcriptional regulation and kinase activities. Amino acid metabolism is also regulated through cell cycle progression. On cancer metastasis, metabolic plasticity, immune evasion, tumor microenvironment adaptation and metastatic site colonization are intricately related to the cell cycle, with distinct regulatory mechanisms at each step of invasion and dissemination. Throughout the synthesis of current understanding, knowledge gaps and limitations in the literature are also highlighted, as are new therapeutic approaches such as combinational therapy and challenges in tackling emerging targeted therapy resistance. A greater understanding of how the cell cycle modulates diverse aspects of cancer biology can hopefully shed light on identifying new molecular targets by harnessing the vast potential of the cell cycle.
引用
收藏
页码:1510 / 1525
页数:16
相关论文
共 218 条
[1]   Computational Identification of a p38SAPK-Regulated Transcription Factor Network Required for Tumor Cell Quiescence [J].
Adam, Alejandro P. ;
George, Ajish ;
Schewe, Denis ;
Bragado, Paloma ;
Iglesias, Bibiana V. ;
Ranganathan, Aparna C. ;
Kourtidis, Antonis ;
Conklin, Douglas S. ;
Aguirre-Ghiso, Julio A. .
CANCER RESEARCH, 2009, 69 (14) :5664-5672
[2]   CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis [J].
Agostinetto, E. ;
Vian, L. ;
Caparica, R. ;
Bruzzone, M. ;
Ceppi, M. ;
Lambertini, M. ;
Ponde, N. ;
de Azambuja, E. .
ESMO OPEN, 2021, 6 (02)
[3]  
Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684
[4]   Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary [J].
Ahmed, Ashour Ahmed ;
Etemadmoghadam, Dariush ;
Temple, Jillian ;
Lynch, Andy G. ;
Riad, Mohamed ;
Sharma, Raghwa ;
Stewart, Colin ;
Fereday, Sian ;
Caldas, Carlos ;
DeFazio, Anna ;
Bowtell, David ;
Brenton, James D. .
JOURNAL OF PATHOLOGY, 2010, 221 (01) :49-56
[5]   Phosphofructokinase: A mediator of glycolytic flux in cancer progression [J].
Al Hasawi, Nada ;
Alkandari, Mariam F. ;
Luqmani, Yunus A. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 92 (03) :312-321
[6]   Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches [J].
Alvarado-Ortiz, Eduardo ;
de la Cruz-Lopez, Karen Griselda ;
Becerril-Rico, Jared ;
Sarabia-Sanchez, Miguel Angel ;
Ortiz-Sanchez, Elizabeth ;
Garcia-Carranca, Alejandro .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
[7]   Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer [J].
Anderson, Marybeth ;
Marayati, Raoud ;
Moffitt, Richard ;
Yeh, Jen Jen .
ONCOTARGET, 2017, 8 (34) :56081-56094
[8]   PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs [J].
Andrzejewski, Sylvia ;
Klimcakova, Eva ;
Johnson, Radia M. ;
Tabaries, Sebastien ;
Annis, Matthew G. ;
McGuirk, Shawn ;
Northey, Jason J. ;
Chenard, Valerie ;
Sriram, Urshila ;
Papadopoli, David J. ;
Siegel, Peter M. ;
St-Pierre, Julie .
CELL METABOLISM, 2017, 26 (05) :778-+
[9]   The CDK4-pRB-E2F1 pathway controls insulin secretion [J].
Annicotte, Jean-Sebastien ;
Blanchet, Emilie ;
Chavey, Carine ;
Iankova, Irena ;
Costes, Safia ;
Assou, Said ;
Teyssier, Jacques ;
Dalle, Stephane ;
Sardet, Claude ;
Fajas, Lluis .
NATURE CELL BIOLOGY, 2009, 11 (08) :1017-U247
[10]  
Bajar BT, 2016, NAT METHODS, V13, P993, DOI [10.1038/NMETH.4045, 10.1038/nmeth.4045]